COURSE DIRECTORS Stéphan HAULON, LILLE, FRANCE Tim RESCH, MALMÖ, SWEDEN STEERING COMMITTEE FOR CRITICAL ISSUES Eric VERHOEVEN, Martin MALINA, John BRENNAN & Richard McWILLIAMS LIMITED SEATS 2012 FINAL PROGRAM 16 TH INTERNATIONAL EXPERTS SYMPOSIUM CRITICAL ISSUES in aortic endografting 2012 www.critical-issues-congress.com May 24 & 25 LILLE - FRANCE 6 CREDITS 9 CREDITS
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
course directorsStéphan Haulon, lille, france
Tim ReSCh, malmö, sweden
steering committee for critical issues
Eric VErhoEVEn, Martin Malina, John BrEnnan & richard McWilliaMs
limited seats
2012
fina
l pr
ogra
m
16th international experts symposium
CritiCal issuesin aortic endografting 2012w w w . c r i t i c a l - i s s u e s - c o n g r e s s . c o m
May 24 & 25lille - france
6 credits 9 credits
Emmanuel aBaTE, Buc, France
Donald aDaM, Birmingham, United Kingdom
Jean-Pierre BECQUEMin, Créteil, France
John BrEnnan, Liverpool, United Kingdom
Peter BUnGaY, Derby, United Kingdom
Piergiorgio Cao, Rome, Italy
Tom CarrEll, London, United Kingdom
nick ChEshirE, London, United Kingdom
roberto ChiEsa, Milan, Italy
Tim ChUTEr, San Francisco, USA
rachel CloUGh, London, United Kingdom
Marc CoGGia, Boulogne, France
Michael DakE, Stanford, USA
Ghislaine DEklUnDEr, Lille, France
Jean-Paul DE VriEs, Nieuwegein, The Netherlands
Eric DUCassE, Bordeaux, France
Marcelo FErrEira, Rio de Janeiro, Brazil
Martin FUnoViCs, Vienna, Austria
Marc GianoTTi, Redwood City, USA
richard GiBBs London, United Kingdom
George haMilTon, London, United Kingdom
reda hassEn-khoDJa, Nice, France
stéphan haUlon, Lille, France
andrew holDEn, Auckland, New Zealand
krassi iVanCEV, London, United Kingdom
Michael JaCoBs, Maastricht, The Netherlands
Piotr kasPrZak, Regensburg, Germany
Tilo kÖlBEl, Hamburg, Germany
ralph kolVEnBaCh,
Düsseldorf, Germany
Mohamed koUssa, Lille, France
Mario laChaT, Zurich, Switzerland
anthony lEE, Bocaraton, USA
Martin Malina, Malmö, Sweden
Blandine MaUrEl, Lille, France
richard McWilliaMs, Liverpool, United Kingdom
Marco MiDUlla, Lille, France
Christoph niEnaBEr, Rostock, Germany
Michael nilson, Flagstaff, USA
alain PraT, Lille, France
Giovanni PraTEsi, Florence, Italy
Thierry rEiX, Amiens, France
Martine rEMY-JarDin, Lille, France
Tim rEsCh, Malmö, Sweden
Vincent riaMBaU, Barcelona, Spain
Blayne roEDEr, Bloomington, USA
Uta rossECk, Karlsruhe, Germany
Jonathan soBoCinski, Lille, France
Björn sonEsson, Malmö, Sweden
Eric sTEinMETZ, Dijon, France
Peter TaYlor, London, United Kingdom
Jörg TEssarEk, Münster, Germany
Matt ThoMPson, London, United Kingdom
Frank VEiTh, New York, USA
hence VErhaGEn, Rotterdam, The Netherlands
Eric VErhoEVEn, Nuremberg, Germany
Frank VErMassEn, Gent, Belgium
Fabio VErZini, Perugia, Italy
Willem WissElink, Amsterdam, The Netherlands
faCu
ltY GE Healthcare
Complex procedures do not require complex solutions. You want a hybrid solution that brings high defi nition vascular imaging and fl exibility in an environment you can be comfortable with. When you know the time is right to expand, advance and improve the care you give, trust a leader in vascular imaging technology.
Merging capabilities. Expanding opportunities. The New Hybrid OR. Learn more at gehealthcare.com/euen/surgery/minimally_invasive_hybrid_OR.html
8.00 thoraCiC aorta Chairmen: S. Haulon, T. Chuter part 1: acute type b dissections
late results from the insTEaD trial, C. Nienaber Update on the aDsorB trial, E. Verhoeven are aortic bare stents needed?, J. Sobocinski GorE side branch endograft, M. Dake Predicting type B aortic dissection outcomes with computational flow
analysis, R. Gibbs Dissection aortic devices, B. Roeder PaNel deBate: Do we need to change the current treatment guidelines in
the treatment of acute uncomplicated type B dissection?
8.50 part 2: unresolved thoracic aorta issues
The celiac trunk should never be covered: current experience with the BolTon MEDiCal scalloped endograft, V. Riambau
Endovascular treatment of mycotic thoracic aneurysms: bridge or definitive option?, P. Taylor
Mixed evidence regarding coverage of the lsa, H. Verhagen retrograde ascending hematoma, M. Dake
PaNel deBate
9.30 iMagiNg Chairmen: T. Resch, R. McWilliams
new CT protocols to lower radiation dose and contrast media volume before and after aortic endografting, M. Remy-Jardin
Fusion imaging: development of a new software, T. Carrell Evaluation of new endografts: can Mri predict failure?, R. Clough Mobile or fixed imaging systems to perform aortic endografting?, S. Haulon Fusion imaging, 3D rotational angiography or Co2 for standard and
complex aortic endografting, K. Ivancev EVar follow-up with Ultra-sound, G. Deklunder PaNel deBate: Should we modify the current eVaR follow-up
recommendations?
10.30 Break on the exhibition hall
LOWERPROFILE,† HYDROPHILIC DELIVERY SYSTEM FOR ENHANCED ACCESS
LONGER LIMB LENGTHS OFFER MULTIPLE OPTIONS TO IMPROVE EASE OF USE
IMPROVED RADIOPACITY FOR INCREASED VISIBILITY TO AID IN GATE CANNULATION‡
11.00 Para reNal aNeurYsMs, PatieNts seleCtioN Chairmen: G. Hamilton, P. Cao
Which patients should not have para renal aneurysms open repair?, E. Steinmetz
Which patients should not have para renal aneurysms laparoscopic repair?, M. Coggia
When can chimneys work?, M. Malina Fenestrated endografts: causes of long term failure, J. Brennan Can the EnDoloGiX nellix repair all para renal aneurysms?, A. Holden results from the French multicentric fenestrated trial: can we predict
outcomes?, J-P. Becquemin PaNel deBate: Which treatment for which patient?
12.00 Para reNal aNeurYsMs, teChNiCal asPeCts Chairmen: P. Taylor, M. Ferreira
secondary procedures after aortic aneurysm repair with fenestrated and branched endografts, J. Tessarek
VasCUTEk fenestrated endograft: current indications and limitations, P. Bungay
EnDoloGiX Ventana off-the-shelf fenestrated endograft: current indications and limitations, A. Holden Cook MEDiCal off-the-shelf fenestrated endograft: current indications and limitations, T. Resch
MEDTroniC abdominal branched endograft: current indications and limitations, W. Wisselink
PaNel deBate: Which endograft for which anatomy?
13.00 lunch on the exhibition hall
14.00 thoraCoaBdoMiNal aNeurYsMs part 1 Chairmen: E. Verhoeven, F. Veith
open or endovascular repair?, P. Cao hybrid repair of thoracoabdominal aortic aneurysms: state of the art, R. Chiesa
Methods of preventing spinal cord ischaemia during Taa open and endovascular surgery, J-P. de Vries
Update on the “sac perfusion branch” to prevent spinal cord ischaemia, K. Ivancev
Endovascular repair: how to minimize post operative risk, T. Resch PaNel deBate: Should only high volume centers perform these procedures?
14.45 thoraCoaBdoMiNal aNeurYsMs part 2 Chairmen: M. Jacobs, B. Sonesson
Pre loaded branched and fenestrated endografts, P. Kasprzak The configuration of sidebranches is important to match anatomy, M. Ferreira “off the shelf” branched endograft: patient selection and sizing, T. Chuter repair of recurrent visceral aortic patch aneurysm after open
thoracoabdominal aortic aneurysm repair, D. Adam Chronic type B dissections: are fenestrated and branched endografts an
option?, S. Haulon PaNel deBate: What are the current contra indications for Taaa
endovascular repair?
15.30 Break on the exhibition hall
16.00 NeW teChNologies - NeW aortiC eNdografts aNd BridgiNg steNts
Chairmen: V. Riambau, K. Ivancev robotic endovascular catheters for arch vessel cannulation, N. Cheshire new generation aTriUM MEDiCal stentgraft, E. Verhoeven CorDis abdominal endograft, G. Pratesi Cook MEDiCal purpose build bridging stents, B. Roeder MEDTroniC next generation abdominal endograft, P. Cao Dissection cutting catheter, M. Nilson new aBBoTT VasCUlar stentgraft projects, M. Gianotti The new generation BarD stent graft for sFa disease, U. Rosseck
Clinical trial results of Treovance, the latest generation of aaa stentgraft, R. Chiesa
PaNel deBate: “new” is “better”? assessment of durability and clinical utility?
17.30 The next generation of hybrid or systems from GE healthcare, E. Abate
18.00 ge cocktail on the exhibition hall
20.30 official dinner
fridaY MaY 25
11.30 asCeNdiNg aorta Chairmen: M. Thompson, A. Prat
What is the best method for precise endograft implantation: rapid pacing, iVC occlusion, drugs?, C. Nienaber
Type a dissections: anatomical studies, J. Sobocinski ascending aorta endografting, R. Kolvenbach Visceral fenestration prior to ascending aorta open repair in acute type a
dissections, M. Midulla Transseptal and transapical antegrade access for TEVar, T. Kölbel ascending aorta endografting: the BolTon MEDiCal experience,
M. Funovics PaNel deBate: Is it time for prospective randomized trial versus open
repair?
12.30 adjournment
w w w . c r i t i c a l - i s s u e s - c o n g r e s s . c o m
8.00 Welcoming coffee
8.15 aBdoMiNal aorta Chairmen: M. Malina, T. Reix
Does EVar suitability impact outcomes of aaa and raaa repair, F. Veith improved results with 3rd generation endografts, F. Verzini Percutaneous closure devices: technique and literature review,
R. Hassen-Khodja Endovascular repair of aorto-enteric fistula: a bridge to surgery?, F. Vermassen Endovascular repair of aortic aneurysms under local anaesthesia, M. Lachat aortic bifurcation occlusive disease: are covered stents an alternative?,
P. Kasprzak PaNel deBate
9.20 iNterNal iliaC BraNCh Chairmen: A. Holden, E. Ducasse
internal iliac occlusion is safe during EVar, F. Veith internal iliac occlusion is unnecessary during EVar, E. Verhoeven Tips and tricks for branched iliac, G. Pratesi Preliminary experience with the bifurcated iliac device, B. Roeder PaNel deBate: Is buttock claudication an issue?
10.00 Break on the exhibition hall
10.30 arCh Chairmen: M. Koussa, S. Haulon MEDTroniC branched endograft, M. Thompson open and hybrid techniques, B. Maurel BolTon MEDiCal branched endograft, A. Lee in-situ fenestrations, B. Sonesson Cook MEDiCal branched endograft, T. Chuter PaNel deBate: Which technique for which patient?
Congress venueWorld Trade Center / Crowne Plaza lille - euralille335 Bd de leeds - lille, 59777 - France Tel. +33 (0)3 20 42 46 46 - Fax. +33 (0)3 20 40 13 14www.lille-crowneplaza.com
Facing the TGV train station, very close to the old city of lille.
Train station: TGV / Eurostar: lille Europe or lille Flandres
airport: lille – lesquin (10km)
road: a1 highway. Follow «lille centre», exit «Gare lille Europe»
Hotel day parking card: 20e (reservation mandatory)
residents, fellows, nurses & technicians . . . . . . . . . . 200€ . . . . . . . . . . . . . . 250€ (a confirmation letter will be asked)
The registration fees include: access to all scientific Medical sessions, access to exhibition hall, welcoming coffees, coffee breaks & the lunch only on Thursday May 24.
hotel accommodationincluding breakfast, city tax not included single double
➊ congress venue: crowne Plaza Lille**** 175,00€ . . . . . . . . . . 175,00€
Cancellation before april 20: refund less 10% (administrative charge). Cancellation after april 20: no refund will be given. name changes will be accepted before May 11. no-shows at the congress will be charged the full fee. refund will be processed until end of september 2012.one night deposit needed to confirm any hotel booking. The whole stay has to be paid before april 20 to avoid cancellation of reservation. City tax is not included.
register online at www.critical-issues-congress.com
official dinnerThursday May 24 (20.30)➎ “au bout des doigts” restaurantregistration mandatory at the registration desk Contribution to costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20€ per person
R E L A Y T h o r a c i c S t e n t - G r a f tWorldwide experience of 5000 patients reached
Manufacturer: Bolton Medical España, S.L.U.c\ Newton 18-24, 08635 – Sant Esteve Sesrovires, Barcelona, Spain +34.93.813.63.23U.S. Headquarters. Bolton Medical Inc. 799 International Parkway, Sunrise, FL 33325, +1.954.838.9699
RELAY PLUS - Caution: Investigational device. Limited by U.S. law to investigational use. RELAY NBS PLUS: Not for sale in the U.S.
Bolton Medical envisions to become a reference in the endovascular treatment of the entire aorta
2005
RELAYThoracic
Stent-GraftCE Mark
2006
BoltonMedical
Custom MadeProgram
RELAY Thoracic Stent-Graft FDA
Phase I Trial Completion
2009
RELAY PLUSThoracic Stent-Graft CE
Mark Approval
2000 Patients treated with theRELAY Thoracic
Stent-Graft Brand
RELAY NBSThoracic Stent-Graft
Halfway point in the U.S. Phase II clinical trial
2010
RELAY NBS PLUS Thoracic Stent-Graft CE Mark Approval
RELAY Thoracic Stent-Graft
FDA Phase II Trial Completion
3000 Patients treated with the RELAY Thoracic
Stent-Graft Brand
2008RELAY NBS
Thoracic Stent-Graft
CE Mark
2007
RELAY Thoracic Stent-Graft
250 mm lengthlowest number of stent-graftper patient